- Integrating systemic agents into multimodality treatment of locally advanced head and neck cancerM R Posner
Mount Sinai School of Medicine, Mount Sinai Medical Center, Tisch Cancer Institute, New York, NY 10029 6574, USA
Ann Oncol 21:vii246-51. 2010....
- Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner
The Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY, USA
Ann Oncol 22:1071-7. 2011..The association between human papillomavirus (HPV) and overall survival (OS) in oropharynx cancer (OPC) was retrospectively examined in TAX 324, a phase III trial of sequential therapy for locally advanced head and neck cancer...